Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 6,701–6,725 of 27,380 studies, newest first · page 269 of 1096.

April 2024 5

  1. 2024-04-01

    Key lessons to improve care—factors contributing to delayed discharges and cost implications: medical conditions and rehabilitation delays at a tertiary rehabilitation center in Saudi Arabia

    ✓ Peer-reviewed Health systems and care delivery International Journal for Quality in Health Care

    Key finding: TBI had the highest percentage (37%) compared to other conditions, which may be attributed to the prevalent challenge of cognitive impairment in TBI in addition to physical disability. +4 more findings

  2. 2024-04-01

    Comparison of phenomic profiles in the All of Us Research Program against the US general population and the UK Biobank

    ✓ Peer-reviewed Long-term cohort studies Journal of the American Medical Informatics Association : JAMIA

    Key finding: Knowledge gained from cohort studies has dramatically advanced both public and precision health. +3 more findings

  3. 2024-04-01

    Sex-specific modulation of amyloid-β on tau phosphorylation underlies faster tangle accumulation in females

    ✓ Peer-reviewed Long-term cohort studies Brain : a journal of neurology

    Key finding: Despite a similar amyloid-β (Aβ) load, a higher load of neurofibrillary tangles (NFTs) is seen in females than males. +3 more findings

  4. 2024-04-01

    Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer

    ✓ Peer-reviewed TREM2 and immune genetics Nature communications

    Key finding: Here, we analyze trajectory inference, deconvolute spatial transcriptomics at single-cell level and perform functional assays to generate a high-resolution integrated map of breast cancer (BC), with a focus on inflammatory and myofibroblastic (iCAF/myCAF) FAP+ CAF clusters. +3 more findings

  5. 2024-04-01

    Evidence of Pericyte Damage in a Cognitively Normal Cohort: Association With CSF and PET Biomarkers of Alzheimer Disease

    ✓ Peer-reviewed Biomarkers Alzheimer disease and associated disorders

    Key finding: We demonstrated a moderate positive correlation between PDGFRβ and both total Tau and phosphorylated Tau 181 in cognitively normal individuals. +3 more findings

March 2024 20

  1. 2024-03-31

    Alzheimer's Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?

    ✓ Peer-reviewed Treatments International journal of molecular sciences

    Key finding: Two antibodies, aducanumab and lecanemab, have been approved by the U.S. +4 more findings

  2. 2024-03-30

    Older adults with reduced cerebrovascular reactivity exhibit high white matter hyperintensity burden

    ✓ Peer-reviewed Vascular contributions Neurobiology of aging

    Key finding: Adjusting for age, sex and intracranial volume, hierarchical regression analysis revealed a significant association between whole brain CVR to hypercapnia and WMH overall [B = -.02, 95% CI (-.04, -.008), p =.003] and in APOE4 carriers [B = -.03, 95% CI (-.06, -.009), p =.009]. +1 more finding

  3. 2024-03-29

    Cryo-EM structures of amyloid-β and tau filaments in Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Nature structural & molecular biology

    Key finding: We found two Aβ 40 filaments (types IIIa and IIIb) that differ from those previously reported in sporadic AD and two types of Aβ 42 filaments (I and II) identical to those found in sporadic and familial AD.

  4. 2024-03-29

    Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue

    ✓ Peer-reviewed Disparities Nature communications

    Key finding: These results expand the structural characterization of LBD Asyn fibrils and approaches for studying disease mechanisms, imaging agents and therapeutics targeting Asyn.

  5. 2024-03-28

    Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging

    ✓ Peer-reviewed Biomarkers EBioMedicine

    Key finding: Tau spatial spread may demonstrate earlier changes than tau burden which could have broad impact in clinical trial design.

  6. 2024-03-27

    Normal-Tension Glaucoma and Potential Clinical Links to Alzheimer's Disease

    ✓ Peer-reviewed Brain scans and imaging Journal of clinical medicine

    Key finding: Recent studies have found significant connections between NTG and cerebral manifestations, suggesting NTG as a neurodegenerative disease beyond the eye.

  7. 2024-03-27
  8. 2024-03-27

    Xenografted human microglia display diverse transcriptomic states in response to Alzheimer's disease-related amyloid-β pathology

    ✓ Peer-reviewed TREM2 and immune genetics Nature neuroscience

    Key finding: To circumvent these issues, here we generated 138,577 single-cell expression profiles of human stem cell-derived microglia xenotransplanted in the brain of the App NL-G-F model of amyloid pathology and wild-type controls. +3 more findings

  9. 2024-03-27

    Delirium and incident dementia in hospital patients in New South Wales, Australia: retrospective cohort study

    ✓ Peer-reviewed Prevention and risk BMJ

    Key finding: The study findings suggest delirium was a strong risk factor for death and incident dementia among older adult patients. +2 more findings

  10. 2024-03-26

    A remote digital memory composite to detect cognitive impairment in memory clinic samples in unsupervised settings using mobile devices

    ✓ Peer-reviewed Cognitive tests and assessment NPJ digital medicine

    Key finding: The derived RDMC score is significantly correlated with the PACC5 score across participants and demonstrates good retest reliability.

  11. 2024-03-26

    ANU-ADRI scores, tau pathology, and cognition in non-demented adults: the CABLE study

    ✓ Peer-reviewed Tau biomarkers Alzheimer's research & therapy

    Key finding: It has been reported that the risk of Alzheimer's disease (AD) could be predicted by the Australian National University Alzheimer Disease Risk Index (ANU-ADRI) scores. +3 more findings

  12. 2024-03-25

    SKA2 regulated hyperactive secretory autophagy drives neuroinflammation-induced neurodegeneration

    ✓ Peer-reviewed Inflammation and the immune system Nature communications

    Key finding: High levels of proinflammatory cytokines induce neurotoxicity and catalyze inflammation-driven neurodegeneration, but the specific release mechanisms from microglia remain elusive. +1 more finding

  13. 2024-03-25

    Messenger RNA-encoded antibody approach for targeting extracellular and intracellular tau

    ✓ Peer-reviewed Drug development Brain communications

    Key finding: Synthetic in vitro-transcribed messenger RNA encoding antibodies for endogenous protein expression holds the potential to overcome many of the limitations associated with protein antibody production. +2 more findings

  14. 2024-03-25

    Plasma glial fibrillary acidic protein in the visual and language variants of Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: GFAP did not correlate with Aβ- or tau-PET cross-sectionally. +2 more findings

  15. 2024-03-25

    Explaining the Variability of Alzheimer Disease Fluid Biomarker Concentrations in Memory Clinic Patients Without Dementia

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: This comprehensive analysis demonstrated that the variance in AD blood biomarker concentrations was mainly explained by age, with minor contributions from cognition, brain atrophy, and genetics, conversely to CSF measures. +2 more findings

  16. 2024-03-23

    Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies

    ✓ Peer-reviewed Brain tissue and pathology Acta neuropathologica

    Key finding: We identified which neuropathologic entities correlate most frequently with one another and demonstrated that the total number of pathologies per individual was directly correlated with cognitive performance as assessed by Clinical Dementia Rating (CDR®) and Mini-Mental State Examination (MMSE). +3 more findings

  17. 2024-03-22

    Association between Mediterranean diet and dementia and Alzheimer disease: a systematic review with meta-analysis

    ✓ Peer-reviewed Prevention and risk Aging Clinical and Experimental Research

    Key finding: Despite the relatively low risk reduction associated with higher adherence to MedDiet among elderly, it should be considered that this population is the most affected. +2 more findings

  18. 2024-03-21

    Key variants via the Alzheimer's Disease Sequencing Project whole genome sequence data

    ✓ Peer-reviewed Genetics Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Seventeen variants were significantly associated with AD within five genomic regions implicating the genes OARD1/NFYA/TREML1, JAZF1, FERMT2, and SLC24A4. +2 more findings

  19. 2024-03-21

    Cell subtype-specific effects of genetic variation in the Alzheimer's disease brain

    ✓ Peer-reviewed Genetics Nature genetics

    Key finding: A new variant influences APOE expression only in microglia and is associated with greater cerebral amyloid angiopathy but not Alzheimer's disease pathology, after adjusting for APOEε4, providing mechanistic insights into both pathologies. +1 more finding

  20. 2024-03-21

    Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias

    ✓ Peer-reviewed Tau biomarkers Brain research

    Key finding: We enrolled 69 individuals diagnosed with Lewy body dementia (LBD), comprising both dementia with Lewy bodies (DLB) (n = 36) and Parkinson's disease dementia (PDD) (n = 33). +3 more findings

Browse the library by subject, with the full score breakdown →